Mixed micelles; for MRA are multicomponent systems containing a phospholipid, a biocompatible non-ionic surfactant (e.g. Synperonic (R) F-108), and a lipophilic gadolinium. complex. A variety of lipophilic gadolinium complexes were designed taking, into account features such as: (i) nature of ligand (cyclic versus acyclic); (ii) lipophilic moiety; (iii) global charge of the complex; and (iv), nature of bond connecting the complex to the lipophilic moiety. All the lipophilic gadolinium complexes after formulation as mixed micelles show high relaxivities in water and in blood (rat). Mixed micelles containing gadolinium complexes bearing only, one aliphatic. chain cannot be used as, MRA contrast agents because they have a high haemolytic effect. Furthermore, in rats they are quickly, eliminated from the blood stream. These drawbacks are completely circumvented using gadolinium complexes bearing two aliphatic chains. Mixed micelles, containing such complexes show high relaxivities, no haemolytic effect and long blood permanence. This, makes them promising candidates as, MRA contrast agents. However, elimination, which occurs exclusively through the liver, is not complete, even after 7 days. Complexes containing labile (e.g. ester) bonds between the lipophilic moieties and the chelate, subunit are eliminated through both the liver and the kidneys. However, elimination is still not complete after 7 days. (C) 2001 Elsevier Science B.V. All rights reserved.